Back

Management of bioprosthetic valve thrombosis following transcatheter tricuspid valve replacement

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Tricuspid intervention procedure and outcome Treatment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Steffen D Kriechbaum

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)

5 More presentations in this session

Presentation thumbnail
Self-care interventions in valvular heart disease improve important patient outcomes: results from a systematic review
Doctor H. Dollaku (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Influence of device evolution in MitraClip and PASCAL systems on clinical outcomes in high-risk patients with degenerative mitral regurgitation and complex anatomy: results from the PRIME-MR registry
Doctor C. Pauschinger (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Haemodynamic effect of transcatheter tricuspid valve annuloplasty and its association with clinical outcomes
Doctor C. Iliadis (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
The impact of tricuspid annuloplasty on right heart parameters: a 3D echocardiography study
Mr D. Verikas (Kaunas, LT)
Abstract Slides Video
Presentation thumbnail
Serial cardiac remodeling and organ function changes after transcatheter tricuspid valve repair in patients with severe tricuspid regurgitation: Importance of multimodal assessment post-TTVR
Doctor D. Liu (Wuerzburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Tricuspid intervention procedure and outcome

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Hypercoagulability and inflammation indicate increased risk for hypoattenuated leaflet thickening in patients with transcatheter aortic valve replacement
thumbnail
Congress Session
Transcatheter solutions for difficult valve problems
thumbnail
Congress Session
Tricuspid valve intervention: ready for prime time?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources